A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Clinical trial NCT06475300 · RECRUITING
Trial details
- NCT number
- NCT06475300
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2027-06-01
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.